Actithera Secures $75.5 Million in Oversubscribed Series A to Innovate Radioligand Therapy Actithera has raised $75.5 million in a Series A financing round led by major investors to advance its precision radioligand therapy platform for clinical development.

Actithera Secures $75.5 Million in Oversubscribed Series A to Innovate Radioligand Therapy #Norway #Oslo #Series_A_Financing #Radioligand_Therapy #Actithera

Varana Capital's Strategic Investment in Arcuro Medical: A Milestone for 2025 Growth Varana Capital leads the Series A financing for Arcuro Medical, enhancing its growth potential in 2025 with innovative medical technology.

Varana Capital's Strategic Investment in Arcuro Medical: A Milestone for 2025 Growth #United_States #Denver #Varana_Capital #Arcuro_Medical #Series_A_Financing